The Evaluation of Pulmonary Function Tests in Patients with Polycystic Ovary Syndrome

Authors

  • Davood Attaran Pulmonologist, Chronic Obstructive Pulmonary Disease Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Haleh Rokni Endocrinologist, Endocrinology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Mahdis Maraashi Resident of Internal Medicine, Chronic Obstructive Pulmonary Disease Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad , Iran
  • Morteza Taghavi Endocrinologist, Endocrinology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • Sajad Ataei Azimi Resident of Internal Medicine, Chronic Obstructive Pulmonary Disease Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad , Iran
  • Shahrzad M.Lari Pulmonologist, Cardio- Thoracic Surgery & Transplant Research Center, Emam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Abstract:

Introduction: Recently a relation between female sex hormones and severity of asthma symptoms has been proposed. As a common endocrine dysfunction, polycystic ovary syndrome (PCOS) could significantly influence the level of sex hormones in PCOS patients. Regarding the possible role of sex hormones in airway physiology, the present study was conducted to survey the effects of PCOS on pulmonary function test parameters. Materials and Methods: In this cross-sectional study 30 recently diagnosed patients with PCOS without history of pulmonary disease were enrolled and 20 healthy women were considered as the control group according to their age, weight, and height. The patients and the controls underwent body plethysmography to measure pulmonary function tests. Results: The mean age of the patients and the controls were 29.43±7.8 and 30.0±7.6 years respectively. There were no statistically significant differences in all pulmonary function test parameters between the patients and the controls (p>0.05). After dividing the patients into 2 groups based on their body mass index (BMI), BMIConclusion: Our results showed that pulmonary function test parameters are not different in PCOS patients comparing to healthy women. Only the deleterious effects of high BMI on pulmonary function can be occurred in these patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

the evaluation of pulmonary function tests in patients with polycystic ovary syndrome

introduction: recently a relation between female sex hormones and severity of asthma symptoms has been proposed. as a common endocrine dysfunction, polycystic ovary syndrome (pcos) could significantly influence the level of sex hormones in pcos patients. regarding the possible role of sex hormones in airway physiology, the present study was conducted to survey the effects of pcos on pulmonary f...

full text

Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran

Background The prevalence of metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS) has been studied in different populations, but their results were so controversial regarding Iranian women. These controversial data indicated the need for more investigation of MetS characteristics in PCOS patients in our population. So this study aimed to evaluate the clinical and laboratory characteris...

full text

Pnm-29: Effects of Vitamin D Supplementation in Reproductive Function of Women with Polycystic Ovary Syndrome

Background Vitamin D deficiency is common in women with PCOS. Vitamin D is thought to influence the development of PCOS through gene transcription, and hormonal modulation influences insulin metabolism and fertility regulation. Therefore, the aim of this review article is to study the effects of vitamin D supplementation in reproductive function of PCOS women. MaterialsAndMethods This review ar...

full text

The Effect of Sitagliptin on Inflammatory Mediators in the Ovary of Rat with Polycystic Ovary Syndrome

Background and Aims: Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disease in females of reproductive age and is a significant infertility cause. Inflammation plays a crucial role in the pathogenesis of PCOS. The present study evaluated whether sitagliptin, dipeptidyl peptidase-4 inhibitor, attenuates inflammatory markers C-reactive protein (CRP), interleukin(IL)-6, tumor necro...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 1  issue 3

pages  84- 88

publication date 2013-10-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023